Automated monitoring of symptoms during ambulatory chemotherapy and oncology providers’ use of the information: a randomized controlled clinical trial

• Published in: Supportive care in cancer 2014-09, Vol.22 (9), p.2343-2350
• Main Authors: Mooney, Kathi H., Beck, Susan L., Friedman, Robert H., Farzanfar, Ramesh, Wong, Bob
• Format: Article
• Language: English
• Subjects: Adult; Aged; Aged, 80 and over; Ambulatory care; Antineoplastic Agents - therapeutic use; Cancer; Chemotherapy; Clinical outcomes; Clinical trials; Electronic Mail; Female; Humans; Internet; Male; Medicine; Medicine & Public Health; Middle Aged; Monitoring systems; Monitoring, Physiologic - methods; Neoplasms - therapy; Nursing; Nursing Research; Oncology; Original Article; Pain Medicine; Patient Satisfaction; Rehabilitation Medicine; Self Care - methods; Self Report; Telecommunications; Telephone
• ISSN: 0941-4355; 1433-7339
• DOI: 10.1007/s00520-014-2216-1

Purpose Monitoring patient-reported symptoms is necessary to adjust and improve supportive care during chemotherapy. Continuing advances in computerized approaches to symptom monitoring can enhance communication about unrelieved symptoms between patients and oncology providers and may facilitate intensified symptom treatment. Methods An automated IT-based telephone monitoring system was developed to enable oncology providers to receive and act on alert reports from patients about unrelieved symptoms during chemotherapy treatment. Daily, 250 participants (randomized to treatment or attentional control) were asked to call the automated system to report presence, severity, and distress for common chemotherapy-related symptoms (1–10 scale if present). For the treatment group, symptoms exceeding preset thresholds for moderate-to-severe intensity levels generated emailed alert reports to both the patient’s oncologist and oncology nurse. Results Patients reported high satisfaction and ease of use of the automated system. Over 80 % of providers reported usefulness of the symptom alert reports. Ten monitored symptoms resulted in, on average, nine moderate-to-severe intensity alerts per patient over 45 study days. However, providers rarely contacted patients after receiving alerts. There were no significant differences in change of symptom severity between the two groups (mean difference = 0.06, p  = 0.58). Conclusion Despite patients’ use of a daily symptom monitoring system and providers’ receipt of information about unrelieved symptoms of moderate-to-severe intensity, oncology physicians and nurses did not contact patients to intensify symptom treatment nor did symptoms improve. Further research is indicated to determine if oncology providers initiated follow-up to intensify symptom treatment, whether symptom outcomes would improve.